thursday, february 20th 2014 -...

Thursday, February 20th 2014

14:00-19:30 Registration Hours

19:30-21:00 Get-together Reception

Friday, Feb 21st 2014

All Day Registration

8:30-9:30 Opening Ceremony

8:30-9:00

Greetings Professor Uri Elkayam, CPP 2012 Congress chairman

Awards

Presentation of 2014 Awards for distinguished contributions.

Presented by:

Jane Sommerville

Imperial college, London, United Kingdom

Jolien Roos-Heeselink

Erasmus Medical Center, Rotterdam, The Netherlands

9:00-9:30 Opening Lecture Pregnancy, Prosthetic Valves and Anticoagulation - Evolving search for safe and effective treatment

Uri Elkayam

University of Southern California, Los Angeles California, USA

9:30-11:00 Preconception and Gestational Evaluation and Counseling

Chairs: Jane Samuel Sommerville, Jolien Roos-Hasselink

9:30-9:45

Approach to risk stratification: past, present and future

Samuel Siu

Schulich School of Medicine and Dentistry, The University of Western Ontario

9:45-10:00

Pregnancy After Cardiotoxic Cancer Treatment: From preconception evaluation through clinical outcomes

Marla Mendelson

Northwestern Memorial ,Northwestern’s Feinberg School of Medicine, Chicago, USA,

10:00-10:15

Pregnancy in the undifferentiated cardiac patient

Jack Colman

Mount Sinai Hospital Toronto, Toronto Canada

10:15-10:30

Prepregnancy Medical Risk Assessment of Older Women Seeking Assisted Reproduction

Paul Gibson

University of Calgary, Calgary, Canada

10:30-10:45

The use of reproduction technologies in the setting of complex heart disease

Norbert Gleicher

Center for Human Reproduction. New York, NY, USA

10:45-11:00 Alternatives for patients unable to sustain a pregnancy - medical and moral issues

Rafael Hirsch

Rabin Medical Center – Beilinson Campus, Petah Tikva, Israel

11:00-11:15 Coffee Break, Poster Viewing and Exhibition Visit

11:15-12:30 Physiologic changes and Cardiac Imaging in pregnancy

Chairs: Thomas Easterling, Naqvi Tanseem 11:15-12:30

Cardiovascular disease in the Fetus

Chairs: Yagel Simcha , Norbert Gleicher

11:15-11:30

Maternal physiological adaptations to pregnancy

Thomas Easterling University of Wahington, Seatle, Wahington,

USA

11:15-11:30

New modalities in 3D/4D ultrasound in the early and late

assessment of the fetal heart

Simcha Yagel

Hadassah University Hospital, Jerusalem, Israel

11:30-11:45

Cardiovasular Imaging of the pregnancy patient

Patrick Colletti

University of Southern California, Los Angeles, California USA

11:30-11:45

In utero treatment of fetal cardiac diseases

Ulrich Gembruch

University of Bonn, Bonn, Germany

11:45-12:00

CT during pregnancy

Sahni Gagan

Mount Sinai Medical Center, New York, NY, USA

11:45-11:55

Atrioventricular conduction delay in the second trimester

measured by fetal magnetocardiography

Annette Wacker-Gussmann

Department of Neonatology, University Children's Hospital

Tuebingen, Germany

1200-12:15

Guidelines for MRI in the pregnant patient

Patrick Colletti

University of Southern California, Los Angeles, California USA

11:55-12:05

Treatment and outcome of fetal heart disease diagnosed by

fetal echocardiogram

Carolina Capuruco

Fetal cardiology, DOPSOM and pediatric and fetal cardiology,

UFMG, Brazil

12:15-12:30

Morphological and functional changes in normal pregnancy:

Insights from 3d and deformational echocardiographic

techniques

Tasneem Naqvi

Mayo Clinic Arizona

12:05-12:15

Isolated Anomalous Development Of Myocardium During Fetal

Life

Maria Prioli

Pediatric Cardiology Unit, Division of Cardiology, Azienda

Ospedaliera Universitaria Integrata Verona, Italy

12:15-12:30

Extra-cardiac congenital anomalies and the impact on fetal

cardiac function

Yagel Simcha

Hadassah University Hospital, Jerusalem, Israel

12:30-14:00

LUNCH BREAK

AND

EXHIBITION VISIT

LUNCH SESSION – Case Presentations 12:50-13:50

Chairs: Uri Elkayam, Carole Warnes, Samuel Siu

12:50-13:00

Patient-Prosthesis Mismatch in Pregnancy: A Case Report

Robert Johnston

Obstetrics & Gynecology, Univerisity of California, Irvine and

Obstetrics & Gynecology, Long Beach Beach Memorial Medical

Center, USA

13:00-13:10

Subplacental bleeding in pregnant women with a Fontan

Petronella G Pieper

University Medical Center, Groningen, The Netherlands

13:10-13:20

Aortic Dissection in The Third Trimester of Pregnancy in a

Pluriparous Without Risk Factors

Filippos Filippakos

Department of Gynecology and Obstetrics, Ospedale Civico,

Lugano, Switzerland

13:20-13:30

Progressive Cardiac Dysfunction in Bethlem Myopathy during

Pregnancy

Anne Floeck

Obstetrics and Prenatal Medicine, University Medical School Bonn,

Germany

13:30-13:40

To Anticoagulate or Not to Anticoagulate, That is the

Question

Winnie Sia

Departments of Medicine and Obstetrics and Gynecology,

University of Alberta, Canada

14:00-15:30 European Registries: status and results

Chairs: Jolien Roos-Hesselink, Mark Johnson Cardiovascular disease in the Fetus

Chairs: Moti Halak, Ulrich Gembruch

14:00-14:15

Registry of pregnancy and Cardiac Disease (ROPAC):Current

status

Jolien Roos-Hesselink


14:00-14:10

Non-Invasive Fetal Electrocardiogram during Pregnancy:

Possibilities of Detecting Heart Disease

Rik Vulling

Electrical Engineering, Eindhoven University of Technology, The

Netherlands

14:15-14:30

Mode of delivery in ROPAC

Mark Johnson

Imperial College London, Chelsea and Westminster

Campus,Chelsea, United Kingdom

14:10-14:20

A prenatal diagnosis of Ebstein's anomaly and Down's syndrome

and its good outcome

Carolina Capuruco

Fetal cardiology, DOPSOM and pediatric cardiology, Biocor

Institute, Brazil

14:30-14:45

Use and impact of Cardiac medication during pregnancy:

Lessons from ROPAC



14:20-14:30

Uteroplacental Blood Flow, Cardiac Function, and Pregnancy

Outcome in Women With Congenital Heart Disease Ali Balci,

Academic Medical Center, The Netherlands

14:45-15:00

Heart failure in pregnancy (ROPAC)

Titia Ruys


14:30-14:40

Echocardiographic Measurement of Maternal Left Ventricular

Strain Correlates with Birthweight

Hong Zheng

Division of Cardiology, University of California San Francisco, USA

15:00-15:15

Arrhythmias in ROPAC

Amar Salam

Cardiology, Al-khor Hospital, Hamad Medical Corporation, Weill

Cornell Medical College-Qatar, Doha, Qatar

14:40-15:30

Valvular Heart disease Chairs: Carole Warnes, Candice Silversides

15:15-15:30

The Euro Obs registry on PPCM – status report

Karen Sliwa

Hatter Institute of Cardiovascular Research in Africa, South

Africa

14:40-14:50

Case: Mechanical Heart Valve Thrombosis in Early Pregnancy

Sorel Goland

The Heart Institute, Kaplan Medical Center, Rehovot, Affiliated

to the Hebrew University and Hadassah Medical School,

Jerusalem, Israel, Israel

14:50-15:00

Case: Severe aortic and mitral stenosis presenting in

cardiogenic shock

Anil Mehra


15:00-15:10

Maternal and Fetal Outcomes in Pregnant Women with Severe

Mitral Stenosis Undergoing Balloon Mitral Valvotomy prior to

Delivery

Jayson Potts

National Women's Health, Auckland City Hospital, New Zealand

15:10-15:20

Case: Infective endocarditis with large mitral valve vegetation

at the 28'th week of pregnancy

Anna Polewczyk

II Cardiology Clinic, Swietokrzyskie Cardology Center, Poland


15:45-18:15 Congenital Heart Disease (CHD) Chairs: Jack Colman, Marry Canobbio

15:45-18:15 Hypertension, Preeclampsia and Eclampsia

Chairs:, Koren Gideon, Arany Zoltan

15:45-16:00

Is there a risk to pregnancy in women with simple

congenital heart disease?

Sabrina Phillips

Mayo Clinic, Rochester, Minnesota, USA

15:45-16:00

Pharmacology of cardiovascular drugs in pregnancy

Thomas Easterling

University of Washington, Seattle, USA

16:00-16:15

Knowledge gap of women with congenital heart

disease and their parents on the risk of pregnancy?

Saidi Arwa

University of Florida, Gainesville, Florida, USA

16:00-16:15

Heterogeneity of hemodynamic profile in pregnancy induced

hypertension

Claudio Borghi Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy

16:15-16:30

Pregnancy in the patient post Fontan operation:

Results of A registry

Mary Canobbio Ahmanson UCLA Adult Congenital Heart Disease, Los Angeles, USA

16:15-16:30

Preeclampsia, gestational hypertension and diabetes – markers

for future cardiovascular risks

Joan Briller University of Illinois at Chicago, Chicago, USA

16:30-16:45

Pregnancy in women with a systemic right ventricle

Carole Warnes

Mayo Clinic, Rochester, Minnesota USA

16:30-16:45

Antiangiogenic biomarkers in preeclampsia: Use for diagnosis and

prognosis

Zoltan Arany

Beth Israel Deaconess Medical Center, Boston, USA

16:45-17:00

The management of pregnancy in the woman with

transposition of the great vessels

Marla Mendelson

Northwestern’s Feinberg School of Medicine, Chicago,

USA, Northwestern Memorial

16:45-17:00

Hypertension in Pregnancy and long term fetal development

Koren Gideon Hospital for Sick Children, University of Toronto, Toronto, Canada

17:00-17:10

The Birth Rate and Case History with Patients

after Correction Operation

of a Fallot Tetralogy

Carl Kopczak Matias

Department of Surgery, Medical University of Graz,

Austria

17:00-17:10

Post-partum Cardiac Structure and Function in Women with

Severe Preeclampsia

Daniela Degli Esposti

Internal Medicine, S. Orsola- Malpighi Hospital- Bologna

University, Italy

17:10-17:20

Pregnant Patients With Ebstein's Anomaly - Clinical

And Echocardiographic Study

Agata Leśniak-Sobelga

Department of Cardiac and Vascular Diseases,

Institute of Cardiology Jagiellonian University

Collegium Medicum, John Paul II Hospital, Poland

17:10-17:20

Chromosome 9p21 rs2383207 polymorphism is associated with

the risk of pre-eclampsia

Agata Sakowicz

Department of Medical Biotechnology, Medical University of Lodz,

Poland

17:20-17:30

Evaluation of pregnancy outcomes in women with

congenital heart disease – a specialized center

experience

André Viveiros Monteiro

Cardiology, Hospital of Santa Marta, Portugal

17:20-17:30

May pregnancy hypertension worsen the structure and function

of left ventricle of women who had previously been healthy?

Sonila Bele

cardilogy, Tirana University, Obstetric & Gynaecologic, Hospital

"Queen Geraldine", Albania

17:30-17:40

Outcome of Pregnancy in Women Totally Repaired

Tetralogy of Fallot

Niloufar Samiei

17:30-17:40

A comparison of blood pressure control by labetolol and

methyldopa during pregnancy

Beck Morten Sorensen

Rapid Fire A Moderators: Elkayam Uri Prof, Sommerville Jane, Prof

Rapid Fire B Moderators: Shotan Avraham Prof, Roos-Hasselink Jolien Prof

1 Valvular Echocardiographic Changes during Pregnancy in Women

with Mitral Stenosis

Candice Silversides

Department of Medicine, Mount Sinai Hospital, Canada

1 Vascular

Dissections and

Aneurysms

Pregnant marfan syndrome patients and the risk of

aortic dissection

Michal Simchen

Obstetrics and Gynecology, Sheba Medical Center,

Sackler School of Medicine, Tel Aviv University, Israel

2 Valvular Optimizing care for women with rheumatic heart disease

in pregnancy:A comprehensive evidence-based antenatal &

intrapartun checklist for the northern territory

Lisa Knight

Obstetrics & Gynaecology, Royal Darwin Hospital, Australia

2 Vascular

Dissections and

Aneurysms

Peripartum acute aortic dissection in single center:

Experience in 9 patients

Sandra Eifert

Herzchirurgie, Herzzentrum Leipzig, Universität

Leipzig, Germany

3 Valvular Retrospective Observational Study to Assess the

Adequacy of Anticoagulation with Low Molecular Weight

Heparin in Women with Prosthetic Heart Valves in

Pregnancy

3 Vascular

Dissections and

Aneurysms

Pregnancy and Delivery in Patients with Aorta and

Aortic Valve diseases

Olga Irtyuga

Specialized Perinatal Centre, Almazov Federal Heart,

Heart Valve Disease Research Center, Rajaie

Cardiovascular Medical & Research Center, Iran

University of Medical Sciences, Iran

Gynaecology and Obstetrics, Odense University Hospital, Denmark

17:40-17:50

Pregnancy Outcome in Women with Repaired

Tetralogy of Fallot

Anne-Sofie Letting

Department of Obstetrics, Oslo University Hospital,

Norway

17:40-17:50

Magnesium Orotate in the Treatment of Pregnant Patients with

Pre-existing Hypertension

Ilshat Gaisin

Internal Medicine, Izhevsk State Medical Academy, Russia

17:50-18:00

Birth control in patients with congenital heart

disease

Saidi Arwa

University of Florida, Gainesville, Florida, USA

17:50-18:05

Short and long term circulatory implications of preeclampsia

Katharine Stanley

Obstetrics and Gynaecology, Norfolk & Norwich University

Hopsital, Norwich, United Kingdom

18:05-18:15

Pre-eclampsia: Evidence of Altered Ventricular Repolarization by

Standard Electrocardiographic Parameters and QT Dispersion

Francesca Parissone

Department of Life and Reproduction Sciences, Obstetrics and

Gynecology Section, University of Verona, Italy

18:15-18:35 Cheese and Wine Reception

18:35-19:50 Rapid Fire Sessions

Sarah Vause

School of Medicine, University of Manchester, United

Kingdom

Blood and Endocrinology Centre., Russia

4 General Heparin-Induced Thrombocytopenia Type II In A

Pregnant Woman With Factor V Leiden Mutation

Agata Leśniak-Sobelga

Department of Cardiac and Vascular Diseases, Institute of Cardiology, Jagiellonian University Collegium Medicum, John

Paul II Hospital, Poland

4 Vascular

Dissections and

Aneurysms

Investigation of factors including differential

diagnosis in hereditary aortic diseases determining

the risk of aortic dissection during pregnancy

Hironobu Hyodo

Department of Integrated Women's Health, St. Luke's

International Hospital and Department of Obstetrics

and Gynecology, The University of Tokyo Hospital, Japan

5 PPCM Predictors of Outcome in Peripartum Cardiomyopathy in

North American Women

Melinda Davis

Department of Medicine, Division of Cardiovascular Medicine,

University of Michigan, USA

5 Hypertension Relationship of cardiac morphofunctional changes with

Brain Natriuretic Peptide (BNP) in differentiating

early-onset preeclampsia from late-onset

preeclampsia

Vera Borges

Obstetrics and Gynecol, Botucatu Medical School, Brazil 6 PPCM Immunosuppresion in the management of peripartum

cardiomyopathy: a case series and literature review

Joyee Basu

Department of Cardiology, Oxford University Hospitals NHS

trust, United Kingdom

6 Hypertension Differentiation between pregnant women with early-

onset preeclampsia from late-onset preeclampsia by

inflammatory cytokines and correlation between IL-

1β and left cardiac hypertrophy

Vera Borges

Obstetric and Gynecol, Botucatu Medical School - UNESP, Brazil

7 PPCM Familial aggregation of dilated cardiomyopathy in patients

with peripartum cadiomyopathy

Kemi Tibazarwa

Medicine, University of Cape Town, South Africa

7 Cardiac surgery Pulsatile Flow Cardiopulmonary Bypass during

Pregnancy

Alessandro Viviano

Cardiothoracic Surgery, St. George’s University

Hospital, United Kingdom

8 Cardiac

Evaluation and

Management

During

Pregnancy

The value of cardiac risk score evaluation in patients with

rheumatic heart disease in pregnancy in Australia

Kylie Burns

The Institute of Cardiac Services, The Townsville

Hospital, Australia

8 Arrhythmias Management of ventricular tachycardia in normal

hearts

during pregnancy - a case series

Rizwan Ahmed

Department of Cardiology, Norfolk and Norwich

University Hospital NHS Trust, United Kingdom 9 Cardiac

Evaluation and

Management

During

Pregnancy

Left Ventricular Structure and Function in Twin Pregnancy

Daniela Degli Esposti

Internal Medicine, S.Orsola-Malpighi Hospital-Bologna

University, Italy

9 Cardiac

Evaluation and

Management

During

Pregnancy

NT-proBNP Predicts Cardiovascular Complications in

Pregnant Women with Congenital Heart Disease

Marlies Kampman

Department of cardiology, University Medical

Center Groningen, and ICIN, Netherlands Heart

Institute, The Netherlands 10 PPCM Mortality as First Manifestation or Early Complication of

Peripartum Cardiomyopathy.

Salima Qamruddin

Department of Cardiology LAC-USC Keck School of Medicine, Los

Angeles, California, United States

10 Cardiac

Evaluation and

Management

During

Pregnancy

Risk Score for Predicting Maternal Complications in

Pregnancy: Which is the Most Suitable for a Spanish

Tertiary Centre Population?

Laura Galian Gay

Cardiology, Hospital Vall d'Hebron, Spain

11 Cardiac

Evaluation and

Management

During

Pregnancy

EXPECT Study – Exercise during Pregnancy Evaluative

Controlled Trial

Rhiannon Davies

College of Engineering, Swansea University, United Kingdom

11 Congenital

Heart Disease

Ebstein's Disease in Pregnancy

Larissa Flosi

Cardiopathy and Pregnancy, Dante Pazzanese Institute

of Cardiology, Brazil

12 General pregnancy outcome of 226 cases with cardiac disease in

pregnancy seen at a single centre in South Africa (Cape

Town)

Karen Sliwa

Hatter Institute of Cardiovascular Research in Africa, Cape

Town, South Africa

12 Congenital

Heart Disease

Pregnancy Outcome and Delivery in Women with

Congenital Heart Disease

Marlies Kampman

Department of Cardiology, University Medical Center

Groningen and ICIN, Netherlands Heart Institute, The

Netherlands 13 Heart Failure Utility of B-Type Natriuretic Peptide (BNP) in Evaluating

Dyspneic Pregnant or Postpartum Women

Niharika Mehta

Women and Infants Hospital, Warren Alpert Medical School

of Brown University, USA

13 Arrhythmias

Prevention of congenital heart block with IVG

Risto Kaaja

Internal Medicine, Satakunta Central Hospital and Turku

University, Finland

14 Coronary

Artery Disease

Should We Establish a New Protocol for the Treatment

of Peripartum Myocardial Infarction?

Philip Houck

Cardiology, Baylor Scott & White Healthcare, USA

14 Arrhythmias Syncope and Arrythmias during Pregnancy

10 Years Experience

Jeryes Shehadeh

Zevoulon and Lady Davis Carmel Medical Centers

Haifa, Israel 15 Coronary

Artery Disease

Spontaneous coronary artery dissection in the peripartum

period

Audrey Quinn

Anaesthesia, Leeds General Infirmary, United Kingdom

15 Arrhythmias

Are Frequent Premature Ventricular Contractions in

Pregnant Patients Always Benign?

Kristopher Knott

NHS Foundation Trust, West Hertfordshire Hospitals

NHS Trust, United Kingdom

Saturday, Feb 22nd 2014

All Day Registration

7:00-8:00

BREAKFAST MORNING SESSION Case Presentations**

Chairs: Uri Elkayam, Avraham Shotan

Successful treatment of two cases of severe aortic stenosis in pregnancy

Samantha Cox

Saint Mary's Hospital, Central Manchester University Hospitals, United Kingdom

Redo Mitral Valve Replacement in Pregnancy with Fetus-based Perfusion Technique

Utku Alemdaroglu

Cardiovascular Surgery, Baskent University Adana Research Center, Turkey

Amniotic Embolism in a Lupic Patient - What´s the Role of Complement activation?

Favorette Campanharo Felipe

Obstetrics, UNIFESP - EPM, Brazil

Two Cases of Pregnancy after Fontan Palliation: Potential Role of Maternal Congestive Hepatomegaly as Protective Effect on Fetal Growth

Line Leduc

Obstetrics & Gynaecology, Universite of Montreal/CHU Ste-Justine, Canada

Inital Manifestation Of DCM Caused By A Mutation In Lamin A/C-Gene In Early Pregnancy

Anna Neugebauer

Medizinische Klinik I, Leopoldina Hospital, Germany

Percutaneous Closure of an Atrial Septal Defect with Severe Pulmonary Hypertension During Pregnancy, using an Amplatzer Occlusion Device

Abdul Wahab Mohamed Jahangir Department of Cardiology, Hospital Pulau Pinang, Malaysia

8:00-10:05 Valvular Heart Disease Chairs: Heidi Connolly , Claire McLintock

8:00-

10:05 General

Chairs: Mathew Sermer, Afshan B Hameed

8:00-8:10

Pregnancy outcomes for women with prosthetic heart valves: a

population-based study

Christine Roberts

Perinatal Research, Kolling Institute, University of Sydney,

Australia

8:00-8:15

The need for proactive and coordinated management of the

pregnant cardiac patient - Part I Mathew

Sermer

Mount Sinai Hospital Toronto, Toronto, Canada

8:10-8:20

Pregnancy in Patients with Mechanical Prosthetic Valves:

Observation in Rural and Semi-urban North Indian Population-

Management Issues at a Tertiary Care Institution

Amrit Gupta

Department of Maternal and Reproductive Medicine (MRH),

8:15-8:25

The effect of maternal heart disease on fetal growth

Emily Gelson

Obstetrics and Gynaecology, Imperial College London, Chelsea and

Westminster Hospital, UK

Sanjay Gandhi Postgraduate Institute of Medical Sciences, India

8:20-8:30

Lowered oral anticoagulation in young pregnant women carrier

of mechanical aortic valve protheses in developing countries

Federica Iezzi

Cardiothoracic surgery, Heart hospital, Albania

8:25-8:35

The Burden of Cardiac Conditions in the Setting of the Brazilian

Network for Surveillance of Severe Maternal Morbidity & Near

Miss

Favorette Campanharo Felipe

Obstetrics, UNIFESP, Brazil

8:30-8:40

The Result of Pregnancy in patients with Significant Mitral

Stenosis

Niloufar Samie

Heart Valve Disease Research Center, Rajaie Cardiovascular

Medical & Research Center, Iran University of Medical Sciences,

Iran

8:35-8:45

Preventing and managing cardiac disease in maternity- a model of

care in a low resource set up

Sliwa Karen

Hatter Institute of Cardiovascular Research in Africa, Cape Town,

South Africa

8:40-8:50

Management of Pregnancy in Women with Mechanical Heart

Valves: a Monocentric 12-year Retrospective French Study

Sabine Aimot-Macron

Gynécologie obstétrique, GH Pitié Salpêtrière, France

8:45-9:00

Top causes of maternal mortality in California

Afshan B Hameed

University of California, Irvine, USA

8:50-9:05

Management of mitral stenosis in pregnancy

Claire McLintock

National Women's Health, Auckland City Hospital, Auckland, New

Zealand

9:00-9:10

A retrospective analysis of maternal mortality associated with

cardiac disease in Columbia: An 8 years review(2000-2008)

Oscar Lavalle

GRICIO, Colombia

9:05-9:20

Twenty years experience of management of prosthetic valves

with pregnancy

Mohamed Mahdy

Cardiothoracic surgery, Alazhar, Egypt

9:10-9:25

Challenges in cardiology research in pregnancy

Tasneem Naqvi

Mayo Clinic, Arizona, USA

9:20-9:35

Challenges in the management patients with Left Heart

Obstructive Lesions

Candice Silversides

University of Toronto, Toronto, Canada

9:25-9:35

Cardiological Complications in Pregnant Patients with Acquired Heart

Disease

Laura Gay Galian

Cardiology, Hospital Vall d'Hebron, Spain

9:40-10: 05

Debate: Should every woman who needs valve replacement

receive a bio-prosthetic valve?

Pro: Rafael Hirsch

Rabin Medical Center – Beilinson Campus, Petah Tikva, Israel

Con: Claire McLintock

National Women's Health, Auckland City Hospital, Auckland, New Zealand


10:20-12:30 Management during pregnancy: Labor and Delivery

Chairs: Mathew Sermer, Katherine Arendt

10:20-10:35

Management of women with heart disease during pregnancy: what do we know, what do we think we know, and what we would like to know?

Samuel Siu

Schulich School of Medicine and Dentistry, The University of Western Ontario, Caqnada

10:35-10:50

The need for proactive and coordinated management of the pregnant cardiac patient – Part II

Mathew Sermer

Mount Sinai Hospital Toronto, Toronto, Canada

10:50-11:05

Obstetric and neonatal complications in pregnant women with heart disease - data of the ZAHARA II

Petronella G Pieper

University Medical Center, Groningen, The Netherlands

11:05-11:20

Pulmonary embolism in pregnancy: specific considerations in diagnosis and treatment

Sahni Gagan

Mount Sinai Medical Center, New York, NY, USA

11:20-11:35

Challenges in the management of labor and delivery in the cardiac patients

Mary Canobbio

Adult Congenital Heart Disease, USA

11:35-11:50

Hemodynamic changes of labor and delivery

Katherine Arendt

Mayo Clinic, Minnesota, USA

11:50-12:05

Role, risk and benefit of interventional cardiology during pregnancy

Presbitario Patrizia

Istituto Clinca Humanitas, Rozzano, Italy

12:05-12:30

Debate: who should determine the mode of delivery?

The Obstetrician – Afshan B Hameed

University of California, Irvine, USA

The Cardiologist – Jorg Stein

Medical University Innsbruck, Innsbruck, Austria

LUNCH SESSION Case Presentations**

12:45-13:45

Chairs: Samuel Siu, Sorel Goland

12:45-12:55

Successful maternal and fetal outcome following resistant congestive cardiac failure due

to Hypertrophic Cardiomyopathy with severe outflow tract obstruction

Yaso Emmanuel

Congenital Cardiology Service, University Hospital Southampton, UK

12:55-13:05

Successful low-dose thrombolysis of submassive pulmonary embolus in a pregnant patient

Harshil Dhutia

Department of cardiology, Northhampton General hospital, United Kingdom

13:05-13:15

Dilated cardiomyopathy and malignant ventricular arrhythmias

Avraham Shotan

Heart Institute, Hillel Yaffe Medical Center, Hadera, Rappaport Medical school, Technion, Haifa,

Israel

13:15-13:25

Unusual Case Of Aortic Disease In Pregnancy: Multimodality Approach

Antonio Campanella

Cardiac Surgery, Hospital of Alessandria, Italy

13:25-13:35

LVAD implantation and heart transplantation in combination with bromocriptine increase

survival in patients with peripartum heart failure

Sandra Eifert

Herzchirurgie, Herzzentrum Leipzig, Universität Leipzig, Germany

13:35-13:45

The Case of a Rare Tumor of the Left Ventricle of a Pregnant

Iuliia Davydova

High Risk Pregnancy, Institute of Pediatrics, Obstetrics and Gynecology, National Academy of

Medical Sciences of Ukraine, Ukraine

14:00-15:40 Arrhythmias

Chairs: Marla Mendelson, Joan Briller 14:00-15:40

Pulmonary Hypertension and Congenital heart Disease

Chairs: Paul Gibson, Eli Gutterman

14:00-14:15

Management of Supraventricular Arrhythmias During

Pregnancy

Marla Mendelson

(Northwestern’s Feinberg School of Medicine, Chicago, USA, Northwestern Memorial)

14:00-14:15

Pulmonary arterial hypertension in pregnancy – What have we

learned over the past decade?

Dianne Zwicke,

Milwaukee Heart Institute, Milwaukee, USA

14:15-14:30

Can we prevent congenital heart block in offspring from

mothers at risk?

Norbert Gleicher Center for Human Reproduction

14:15-14:25

High-Output Heart Failure in a Pregnant Woman Affected by

Undiagnosed Intra-Hepatic Multiple Arteriovenous

Malformations

Valentina Benetti

Cardiology, Azienda Ospedaliera Universitaria Integrata di

Verona, Italy

14:30-14:40

Electrophysiology procedures without fluoroscopy in pregnant

and non pregnant patients

Ayala-Paredes

Cardiology, CHUS Sherbrooke University, Canada

14:30-14:40

Case:Anesthesia consideration for the delivery of patients

with Severe pulmonary hypertension presenting for caesarian

section

Ilse Dons

Erasmus MC, Rotterdam, The Netherlands

14:40-14:50

Ventricular Tachycardia during Pregnancy in Women with

Heart Disease: Data from the Registry on Pregnancy and

Cardiac Disease

Ebru Ertekin

Cardiology, Erasmus University Medical Center, The Netherlands

14:40-14:50

Impact of pregnancy in women after atrial repair for

transposition of the great arteries

Valle Pedrosa

Cardiology, Hospital de Manises, Spain

14:50-15:00

Atrial fibrillation without a cardiac cause in pregnancy: an

international survey on optimal management

Annabelle Cumyn

Obstetrics and Gynecology, Centre Hospitalier Universitaire

Sainte Justine, Canada

14:50-15:00

Outcomes of Pregnancy in Women after Fontan Palliation

Marielle Gouton

Cardiopathies Congénitales de l'adulte, Centre Chirurgical Marie

Lannelongue, France

15:00-15:10

Single Center Experience with Electrophysiology Procedures

During Pregnancy

Orsolya Bene

Institute of Cardiology, University of Debrecen, Hungary

15:00-15:10

Results of Pregnancy in Women with Tetralogy of Fallot

Larissa Flosi

Cardiopathy and Pregnancy, Dante Pazzanese Institute of

Cardiology, Brazil

15:10-15:20

Automated detection of premature atrial contractions in non-

invasive fetal heart rate recordings: a case report

Guy Warmerdam

Faculty of Electrical Engineering, Eindhoven University of

Technology and Department of Medical Physics, Maxima Medical

Center, The Netherlands

15:10-15:20

Supravalvular Aortic Stenosis In Pregnancy

Antonio Campanella

Cardiac Surgery, Hospital of Alessandria, Italy

15:20-15:30

An Unusual Cause for Tachycardia and Electrocardiographic

Changes in A Pregnant Woman

Inna Rosenfeld

Cardiology, Ziv Medical Center, Israel

15:20-15:30

Uncorrected Severe Aortic Coarctation Diagnosed During

Pregnancy

Jonathan Windram

Cardiology, Mazankowski Heart Institute and Obstetric Medicine,

Lois Hole Women's Health Centre, Canada

15:30-15:40

A Retrospective Casenote Review of the Obstetric

Management of Women with Genetic Long QT Syndrome

Douglas Findlay

Department of Obstetrics, St Mary's Hospital, Central

Manchester University Hospitals NHS Foundation Trust, United

Kingdom

15:30-15:40

Comparison of Pregnancy Outcome in Women with Corrected

versus Uncorrected Atrial Septal Defect or Ventricular Septal

Defect

Larissa Flosi

Cardiopathy and Pregnancy, Dante Pazzanese Institute

of Cardiology, Brazil


15:55-17:55 Cardiomyopathies

Chairs: Karen Sliwa, Radha Sarma 15:55-17:55

Aorta and Coronary artery Disease Chairs: Leisa Freeman, Patrizia Presbitero

15:55-16:10

Hypertrophic cardiomyopathy and pregnancy –

review and guidelines

Pieper Petronella,

University Medical center, Groningten, Netherland

15:55-16:10

Pregnancy and aortopathy due to Marfan syndrome and

bicuspid aortic valve

Heidi Connolly,

Mayo Clinic, Rochester Minnesota, USA

16:10-16:25

Predicting adverse cardiovascular outcomes among

pregnant women with structural heart disease -

Who is really at risk and can we prevent bad

things from happening? Mitchell Saltzberg

Christiana Care Health System, Newark, Delaware,

USA

16:10-16:25

Turner's syndrome and recipient pregnancy – what are

the risks for the aorta?

Leisa Freeman

Norfolk & Norwich University Hopsital, Norwich, United

Kingdom

16:25-16:35

Hospital Admissions and Deliveries in Pregnant

Women with Chagas Cardiomiopathy

Daniela Leanza

Obstetrics Clinic, Hospital das Clínicas da Faculdade

de Medicina da Universidade de São Paulo, Brazil

16:25-16:35

Successful Aortic Replacements in Pregnant Women with

Marfan Syndrome

Kamiya Chizuko

Department of Perinatology and Gynecology, National

Cerebral and Cardiovascular Center, Japan

16:35-16:45

Subsequent Pregnancy in Patients with Acute Heart

Failure during Pregnancy with Identifiable

Precipitating Factors

Rafael Kuperstein

The Leviev Heart Institute, Sheba Medical Center,

Tel-Aviv University, Israel

16:35-16:50

This risk of Subsequent pregnancy after coronary

dissection or aortic dissection not related to the

Marfan syndrome

Leisa Freeman

Norfolk & Norwich University Hopsital, Norwich, United

Kingdom

16:45-17:00

Noncompaction and Pregnancy?

Radha Sarma,

Western University of Health Sciences, College of

Osteopathic Medicine of Pacific, Los Angeles, USA 16:50-17:00

Pregnancy and perinatal outcomes at patients with

mesenchymal dysplasias (Marfan's, Ehler-Danlos,

Rendu-Osler syndromes)

Alexander Makatsariya

Department of obstetrics and gynecology, First Moscow

State Medical University, Russia

17:00-17:10

Pregnancy and Delivery in Patients with

Hypertrophic Cardiomyopathy

Daniela Leanza

Obstetrics Clinic, Hospital das Clínicas da Faculdade

de Medicina da Universidade de São Paulo, Brazil

17:00-17:10

Perinatal Outcome in Patients with Takayasu’s Arteritis

Maria Rita Bortolotto

Obstetrics Clinic, Hospital das Clínicas da Faculdade de

Medicina da Universidade de São Paulo, Brazil

17:10-17:20

Unique echocardiographic pattern of apical sparing

in eclampsia-related cardiomyopathy

Stephen Gleich

Department of Anesthesiology, Mayo Clinic, USA 17:10-17:25

Treatment of pregnancy associated Acute myocardial

infarction due to coronary dissection

Patrizia Presbitero Istituto Clinca Humanitas, Rozzano, Italy

17:20-17:30

Open Source Research – A Proposed Method to

Study Peripartum Immune Disease

Philip Houck

Cardiology, Baylor Scott & White Healthcare, USA

17:25-17:40

Management of patients with coronary disease during

pregnancy

Joan Briller,

University of Illinois at Chicago, Chicago, USA

17:30-17:45

Dilated non-peripartum cardiomyopathy in

pregnancy

Avraham Shotan

Heart Institute, Hillel Yaffe Medical Center, Hadera,

Rappaport Medical school, Technion, Haifa, Israel

17:40-17:50

Pregnancy-Related Acute Myocardial Infarction in

Japan-A Review of Epidemiology, Etiology and

Treatment From Case Reports

Hiroshi Satoh

Department of Cardiology, Hamamatsu University School

of Medicine, Japan

Sunday, Feb 23rd 2014

8:00-10:05 Cardiovascular Medications and Arrhytmias

Chairs: Claudio Borghi, Ilan Goldenberg

8:00-8:25

Debate: Should bromocriptine be a standard therapy for PPCM?

Pro: Karen Sliwa Hatter Institute of Cardiovascular Research in Africa,Cape Town, South Africa

Con: Dennis McNamara

University of Pittsburgh Medical Center, Pittsburgh, USA

8:25-8:40

Pharmacology of cardiovascular drugs in pregnancy

Thomas Easterling

University of Washington, Seattle, USA

8:40-8:50

Long-Term Cardiovascular Risk in Women Prescribed Fertility Therapy

Udell Jacob

Cardiovascular Division, Department of Medicine, Women's College Hospital, Ontario, Canada

8:50-9:05

SSRIs in Pregnancy and Cardiovascular Risks in the Baby: The Last Chapter

Gideon Koren

Hospital for Sick Children, University of Toronto, Canada

9:05-9:20

Arrhythmias and pregnancy



9:20-9:35

Fetal arrhythmia – diagnosis and treatment

Ulrich Gembruch

University of Bonn, Germany

9:35-9:50

Long QT in Pregnancy

Ilan Goldenberg,

Sheba Medical Center, Tel Hashomer, Israel

9:50-10:05

Cardiac Arrest in Pregnancy

Candice Silversides

University of Toronto, Toronto, Canada


10:25-11:20 Surgery, Anesthesia and Intervention in Pregnancy

Chairs: Eli Gutterman , Lori Blauwet

10:25-10:40

Cardiac surgery during pregnancy

Sabrina Phillips

Mayo clinic , Rochester Minnesota, USA

10:40-10:55

Anesthesia for the patient with complex congenital heart disease

Sharon Orbach-Zinger

Rabin Medical Center / Bellinson Hospital, Petah, Tikva, Israel

10:55-11:10

Preoperative Assessment of the Pregnant Woman Requiring Noncardiac Surgery

Paul Gibson

University of Calgary, Calgary, Canada

11:10-13:15 Peripartum Cardiomyopathy

Chairs: Uri Elkayam, Dennis McNamara

11:10-11:25

PPCM in Sweden:Risk factors, treatment and outcome

Maria Schaufelberger

Sahlgrenska university hospital, University of Gothenburg, Gothenburg, Sweden

11:25-11:40

Biomarkers for prediction of outcome in PPCM

Dennis McNamara

University of Pittsburgh Medical Center, Pittsburgh, PA, USA

11:40-11:50

Case: Preeclampsia with recent normal LVEF and post cesarean section PPCM

Mordechi Halak

Obstetrics and Gynecology, Hillel Yaffe Medical Center, Hadera, Rappaport Medical School, Technion, Haifa, Israel

11:50-12:05

Vascular dysfunction as a cause for PPCM and potential association with preeclampsia

Zoltan P. Arany

Beth Israel Deaconess Medical Center, Boston, USA

12:05-12:20

The role of the right ventricle in PPCM

Lori Blauwet

Mayo Clinic, USA

12:20-12:30

Racial differences in clinical presentation and outcomes in peripartum cardiomyopathy in the US

Goland Sorel

The Heart Institute, Kaplan Medical Center, Rehovot, The Hebrew University and Hadassah Medical School, Jerusalem, Israel, Israel

12:30-12:45

Pregnancy unmasks genetic cardiomyopathies ; is peripartum cardiomyopathy a genetic disease?

Karin van Spaendonc-Zwarts

University Medical Center Groningen, Netherlands

12:45-13:00

Clinical Characteristics of PPCM in the USA: Results of NHLBI multicentre IPAC study

Dennis McNamara

University of Pittsburgh Medical Center, Pittsburgh, USA

13:00-13:15

The risk of subsequent pregnancy in women with a history of PPCM

Uri Elkayam


13:15-13:20 Closing Remarks

thursday, february 20th 2014 -...

Documents